Gemifloxacin

Gemifloxacin

SCHEMBL136827

CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN.CS(=O)(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

gyrAgyrBparCparE

The experimentally established mechanism targets of Gemifloxacin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 1.00
KDM4E B2RXH2 2/20 1.00
HSD17B10 Q99714 2/20 1.00
ABCC4 O15439 1/20 1.00
DPP4 P27487 6/20 0.93
CHRM2 P08172 1/20 0.93
DRD1 P21728 1/20 0.93
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.47
HPGD P15428 1/20 0.47
XBP1 P17861 1/20 0.47
NFKB1 P19838 1/20 0.47
HTT P42858 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
KCNH2 Q12809 1/20 0.44
DHFR P00374 1/20 0.43
CYP2C9 P11712 1/20 0.40
ATP6V1B2 P21281 1/20 0.40
TBXA2R P21731 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gemifloxacin SCHEMBL2421086 1.00 LMNA (1.00) LMNAKDM4EHSD17B10ABCC4DPP4
Gemifloxacin SCHEMBL3141327 1.00 LMNA (1.00) LMNAKDM4EHSD17B10ABCC4DPP4
Gemifloxacin SCHEMBL1237121 1.00 LMNA (1.00) LMNAKDM4EHSD17B10ABCC4DPP4
Gemifloxacin SCHEMBL29408809 1.00 LMNA (1.00) LMNAKDM4EHSD17B10ABCC4DPP4
Gemifloxacin SCHEMBL2421087 1.00 LMNA (1.00) LMNAKDM4EHSD17B10ABCC4DPP4
Gemifloxacin SCHEMBL5661711 0.99 LMNA (0.98) LMNAKDM4EHSD17B10ABCC4DPP4
Gemifloxacin SCHEMBL5661708 0.99 LMNA (0.98) LMNAKDM4EHSD17B10ABCC4DPP4
Gemifloxacin SCHEMBL3281156 0.99 LMNA (0.98) LMNAKDM4EHSD17B10ABCC4DPP4
Gemifloxacin SCHEMBL3281159 0.99 LMNA (0.98) LMNAKDM4EHSD17B10ABCC4DPP4
Gemifloxacin SCHEMBL5658681 0.99 LMNA (0.98) LMNAKDM4EHSD17B10ABCC4DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 967 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118878838-A Preparation method and application of metal organic framework material for adsorbing quinolone medicines 新疆畜牧科学院畜牧业质量标准研究所(新疆维吾尔自治区种羊与羊毛羊绒质量安全监督检验中心) 2024-11-01 CN claimed
US-20230414584-A1 ADMINISTRATION OF ANTIBIOTIC COMPOUNDS FOR THE TREATMENT OF STREPTOCOCCAL INFECTIONS FOR THE TREATMENT OF PSORIASIS CENTRE FOR DIGESTIVE DISEASES (AU) 2023-12-28 US claimed
CN-116650492-A Administration of antibiotic compounds for the treatment of streptococcal infections to treat psoriasis 消化系统疾病中心 2023-08-29 CN claimed
CN-114814013-B Method for rapidly screening unknown chemical hazard residues in aquatic products based on high-resolution mass spectrum database 中国海洋大学 2023-06-02 CN claimed
EP-4057813-A1 COMPOSITIONS AND METHODS FOR TREATING HUANGLONGBING DISEASE IN CITRUS New Life Crop Sciences LLC (US) 2022-09-21 EP claimed
CN-114980736-A Compositions and methods for treating citrus greening disease 新生命作物科学有限责任公司 2022-08-30 CN claimed
CN-114936109-A Counter-example fault positioning method based on model detection 南通大学 2022-08-23 CN claimed
EP-3951263-A1 METHOD AND SYSTEM FOR MONITORING THE CONTENT OF IRON CONTAINING MATERIALS IN A PARTICULATE ASH STREAM OF A FLUIDIZED BED BOILER Improbed AB (SE) 2022-02-09 EP claimed
CN-113887131-A Responsibility sensitive safety model calibration method facing vehicle cut-in scene 同济大学 2022-01-04 CN claimed
US-11074500-B2 Prediction of social media postings as trusted news or as types of suspicious news BATTELLE MEMORIAL INSTITUTE (US) 2021-07-27 US claimed
US-6340689-B1 CONTACTING ATYPICAL UPPER RESPIRATORY PATHOGENIC BACTERIA, ESPECIALLY LEGIONELLA SPECIES, WITH ANTIBACTERIALLY EFFECTIVE AMOUNT OF COMPOSITION COMPRISING GEMIFLOXACIN COMPOUND OR ANTIBACTERIALLY EFFECTIVE DERIVATIVE THEREOF SMITHKLINE BEECHAM CORPORATION 2002-01-22 US claimed
US-6331550-B1 MODULATING METABOLISM OF ANAEROBIC PATHOGENIC BACTERIA BY CONTACTING BACTERIA WITH ANTIBACTERIALLY EFFECTIVE AMOUNT OF COMPOSITION COMPRISING GEMIFLOXACIN COMPOUND OR DERIVATIVE SMITHKLINE BEECHAM CORPORATION 2001-12-18 US claimed
US-6262071-B1 ADMINISTERING A GEMIFLOXACIN COMPOUND, OR ANTIBACTERIALLY EFFECTIVE DERIVATIVES THEREOF. SMITHKLINE BEECHAM CORPORATION 2001-07-17 US claimed
WO-2001000209-A1 METHODS OF USE OF FLUOROQUINOLONE COMPOUNDS AGAINST BACTERIA SMITHKLINE BEECHAM CORPORATION (US) 2001-01-04 WO claimed
US-5962468-A ANTIBACTERIAL ACTIVITY LG CHEMICAL LTD. (KR) 1999-10-05 US claimed
EP-0465511-B1 DYNAMIC CORRECTION OF SERVO FOLLOWING ERRORS IN A COMPUTER-NUMERICALLY-CONTROLLED SYSTEM AND FIXED CYCLE UTILIZING SAME VICKERS ESD INC (US) 1998-10-07 EP claimed
US-5776944-A 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof LG CHEMICAL LTD. (KR) 1998-07-07 US claimed
EP-0766157-A2 Improvements in and relating to dynamic correction of servo following errors in a computer-numerically-controlled system and fixed cycle utilising same Vickers E.S.D., Inc. (US) 1997-04-02 EP claimed
EP-0465511-A1 DYNAMIC CORRECTION OF SERVO FOLLOWING ERRORS IN A COMPUTER-NUMERICALLY-CONTROLLED SYSTEM AND FIXED CYCLE UTILIZING SAME Vickers E.S.D., Inc. (US) 1992-01-15 EP claimed
WO-1990011574-A1 DYNAMIC CORRECTION OF SERVO FOLLOWING ERRORS IN A COMPUTER-NUMERICALLY-CONTROLLED SYSTEM AND FIXED CYCLE UTILIZING SAME CINCINNATI MILACRON, INC. (US) 1990-10-04 WO claimed